Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
vV8WQatprLDmubZ1